OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CFO Robert Lawrence Golden sold 3,000 shares of the business’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $6.63, for a total transaction of $19,890.00. Following the completion of the sale, the chief financial officer directly owned 91,291 shares in the company, valued at $605,259.33. This represents a 3.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Robert Lawrence Golden also recently made the following trade(s):
- On Tuesday, September 15th, Robert Lawrence Golden sold 3,000 shares of OneMedNet stock. The shares were sold at an average price of $6.30, for a total transaction of $18,900.00.
OneMedNet Price Performance
ONMD stock traded down $0.52 during trading hours on Friday, reaching $4.30. The stock had a trading volume of 24,653 shares, compared to its average volume of 69,105. The stock has a 50-day simple moving average of $6.24 and a 200 day simple moving average of $7.32. OneMedNet Corporation has a fifty-two week low of $4.30 and a fifty-two week high of $42.20. The stock has a market capitalization of $25.50 million, a PE ratio of -2.69 and a beta of 1.14.
Analyst Ratings Changes
Check Out Our Latest Research Report on ONMD
About OneMedNet
OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.
The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.
Further Reading
- Five stocks we like better than OneMedNet
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
